Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging | SpringerLink
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. - Abstract - Europe PMC
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
Prognostic factors for operable biliary tract cancer: serum levels of | OTT
Univariate analysis of CA 19-9 and CEA as a categorical variable | Download Table
![PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c14d81ca234c0d592f2e72050604bd015d1da96f/3-Table3-1.png "PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar")
PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
Combinatorial Serum Markers for CCA Diagnosis | Download Scientific Diagram
CA 19-9 Antigen - an overview | ScienceDirect Topics
The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology
The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma - Jaklitsch - Translational Gastroenterology and Hepatology
PDF) CA 242, a new tumour marker for pancreatic cancer: A comparison with CA 19-9, CA 50 and CEA
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Cancers | Free Full-Text | The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
Diagnostic Role of Serum CA 19-9 for Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis - ScienceDirect
CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma - FullText - GE - Portuguese Journal of Gastroenterology 2017, Vol. 24, No. 3 - Karger Publishers
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
